Depth before deals

Turning BioPharma assets into strategic alliances.

PhD-level insight to connect emerging biotech, Big Pharma, and private equity across borders.

Get in touch

How we can help

Commercialization

We define the path to market for BioPharma innovators, aligning clinical, regulatory, and commercial to reach patients.

Commercialization

We define the path to market for BioPharma innovators, aligning clinical, regulatory, and commercial to reach patients.

Commercialization

We define the path to market for BioPharma innovators, aligning clinical, regulatory, and commercial to reach patients.

BD&L And Partnering

Efficiency and effectiveness are vital for success. Exora helps optimize processes, reduce costs, and boost productivity.

BD&L And Partnering

Efficiency and effectiveness are vital for success. Exora helps optimize processes, reduce costs, and boost productivity.

BD&L And Partnering

Efficiency and effectiveness are vital for success. Exora helps optimize processes, reduce costs, and boost productivity.

Learn More

Our offering

We provide end-to-end BD, licensing, and commercialisation support for BioPharma innovators, shaping partnering strategy, qualifying and engaging global counterparties, structuring and negotiating deals, and aligning routes-to-market so high-potential assets secure the right partners, terms, and access to patients across key markets.

Partnering strategy

BD pipeline design & targeting

Licensing & deal structuring

Go-to-market planning

Learn More

Our mission & vision

Our mission is to turn differentiated BioPharma science into global impact through sharp BD, rigorous licensing, and focused commercialisation, all driven by deep domain expertise.

Exora is dedicated to unlocking your organization's potential by solving growth, and sustainability challenges. Let us be your key to unraveling business mysteries.

Asset & partnering strategy

We clarify asset positioning and partnering strategy so the right global counterparties see the value fast.

Asset & partnering strategy

We clarify asset positioning and partnering strategy so the right global counterparties see the value fast.

Asset & partnering strategy

We clarify asset positioning and partnering strategy so the right global counterparties see the value fast.

BD pipeline & outreach

We design and run targeted BD campaigns, qualifying and progressing conversations from first intro to term sheet.

BD pipeline & outreach

We design and run targeted BD campaigns, qualifying and progressing conversations from first intro to term sheet.

BD pipeline & outreach

We design and run targeted BD campaigns, qualifying and progressing conversations from first intro to term sheet.

Licensing & deal structuring

We build licensing constructs and economics that balance risk, upside, and strategic control.

Licensing & deal structuring

We build licensing constructs and economics that balance risk, upside, and strategic control.

Licensing & deal structuring

We build licensing constructs and economics that balance risk, upside, and strategic control.

Commercialisation

We map priority markets, routes-to-market, and launch partners to accelerate adoption and revenue.

Commercialisation

We map priority markets, routes-to-market, and launch partners to accelerate adoption and revenue.

Commercialisation

We map priority markets, routes-to-market, and launch partners to accelerate adoption and revenue.

Strategic insights

We connect clinical, regulatory, and competitive insight into practical choices on where, when, and how to partner.

Strategic insights

We connect clinical, regulatory, and competitive insight into practical choices on where, when, and how to partner.

Execution excellence

We manage cross-border negotiations, workstreams, and governance so signed deals translate into performance.

Execution excellence

We manage cross-border negotiations, workstreams, and governance so signed deals translate into performance.

Strategic insights

We connect clinical, regulatory, and competitive insight into practical choices on where, when, and how to partner.

Execution excellence

We manage cross-border negotiations, workstreams, and governance so signed deals translate into performance.

Risk and compliance

We assess and mitigate risks ahead of time to secure essential assets and credibility.

View All Solutions

Deep network throughout Asia, EU and the USA

A compact senior bench, connecting emerging biotechs, big pharma and private equity across borders, adding global BD&L and capital reach to our work.

Kristoffer Danielsson

CEO & founder

Kristoffer Danielsson

CEO & founder

Kristoffer Danielsson

CEO & founder

Victor Levitsky

Senior Scientist

Victor Levitsky

Senior Scientist

Victor Levitsky

Senior Scientist

Andreas W. Sailer

Business advisor

Andreas W. Sailer

Business advisor

Andreas W. Sailer

Business advisor

Jan Stenberg

Medical Advisor

Jan Stenberg

Medical Advisor

Jan Stenberg

Medical Advisor

Ryan De Mars

Junior Consultant

Ryan De Mars

Junior Consultant

Ryan De Mars

Junior Consultant

We align BioPharma innovation, capital, and strategy cross borders.

We connect visionary researchers and impact-driven investors to shape the future of healthcare.

We align BioPharma innovation, capital, and strategy cross borders.

We connect visionary researchers and impact-driven investors to shape the future of healthcare.

We align BioPharma innovation, capital, and strategy cross borders.

We connect visionary researchers and impact-driven investors to shape the future of healthcare.